ST-elevation myocardial infarction
Therapeutic area
Cardiology
Rare disease
No
- Definition
- A very serious type of heart attack during which one of the heart’s major arteries (one of the arteries that supplies oxygen and nutrient-rich blood to the heart muscle) is blocked. ST-segment elevation is an abnormality detected on the 12-lead ECG.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- ST-elevation myocardial infarction
- Therapeutic area
- Cardiology
- ST-elevation myocardial infarction
- ST segment elevation myocardial infarction
- STEMI
- acute-ST segment elevation myocardial infarction
- All therapeutic areas
- Cardiology
- Severity
- Severe
- MONDO ID
- MONDO:0041656
- Parent condition
- MONDO:0004781
Related records
Broader conditions (9)
- Acute disease
- Acute myocardial infarction
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Heart disorder
- Human disease
- Myocardial disorder
- Myocardial infarction
Trials (815)
- 10-Years Follow-up of the EXAMINATION Trial
- 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
- 3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions
- A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor
- A Cohort Study of Correlation Between Mast Cells and Prognosis in Patients With Acute Myocardial Infarction
- A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
- A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
- A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
- A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
- A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI
- A Pilot Study of Transcoronary Myocardial Cooling
- A Polypill for Secondary Prevention of Ischemic Heart Disease
- A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the US
- A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI
- A Prospective Multicenter Clinical Study on the Long-term Prognosis of Patients With ST-segment Elevation Myocardial Infarction Using Cardiac Magnetic Resonance Imaging.
- A Randomized Clinical Evaluation of the BioFreedomâ„¢ Stent
- A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
- A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI
- A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI
Approved drugs (1)
- Reteplase
Drugs in development (43)
- Abciximab Phase 3
- Acetylcysteine Phase 2
- Adenosine Phase 2
- Aspirin Phase 3
- Atorvastatin Phase 3
- Atorvastatin calcium Phase 3
- BQ-123 Phase 2
- Cangrelor Phase 2
- Canrenoate potassium Phase 3
- Cenderitide Phase 1
- Clopidogrel Phase 3
- Colchicine Phase 3
- Danegaptide Phase 2
- Dapagliflozin Phase 3
- Dutogliptin Phase 3
- Empagliflozin Phase 2
- Enalapril Phase 3
- Enoxaparin sodium Phase 3
- Epoetin alfa Phase 2
- Eptifibatide Phase 2